ARCHIVES

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 44 | December 2, 2005

Download PDF Visit The Full Archive

Related Articles

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

November 26, 1999

In Brief: Center wins $10 Million To coordinate Study; Albert Einstein Center Name Comprehensive

December 5, 1997

DeVita Appointment Now Official; Calls For New Chemoprevention Program, More Applied Prevention

July 18, 1980

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

August 5, 2005

Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs

March 22, 2002